『S22:E2 – Advances in TROP2-directed ADCs for Non-Small Cell Lung Cancer: First-Line and Combination Therapies』のカバーアート

S22:E2 – Advances in TROP2-directed ADCs for Non-Small Cell Lung Cancer: First-Line and Combination Therapies

S22:E2 – Advances in TROP2-directed ADCs for Non-Small Cell Lung Cancer: First-Line and Combination Therapies

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

In this episode, our Faculty, Dr. Charu Aggarwal and Dr. Jacob Sands, discuss ongoing clinical trials, evolving biomarker approaches using Quantitative Continuous Scoring (QCS), and the future of personalized care in lung cancer.

Visit https://suitehome.atpointofcare.com/library/2674.02/page/0?subdomain=nsclc to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

This podcast is powered by Pinecast.

S22:E2 – Advances in TROP2-directed ADCs for Non-Small Cell Lung Cancer: First-Line and Combination Therapiesに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。